# Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advanced Breast Cancer

> **NCT07708922** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fudan University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07708922
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2029-07-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708922, "Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advanced Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*